Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts

机译：通过不同的嗜酸细胞计数使用较高的吸入糖皮质激素剂量治疗COPD患者的有效性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundBlood eosinophil counts have been documented as a good biomarker for patients with chronic obstructive pulmonary disease (COPD) using inhaled corticosteroid (ICS) therapy. However, the effectiveness and safety of prescribing high or medium dose of ICS for patients with different eosinophil counts are unknown.

机译：背景嗜酸性粒细胞计数已被记录为使用吸入皮质类固醇（ICS）治疗的慢性阻塞性肺疾病（COPD）患者的良好生物标志物。但是，对于不同嗜酸性粒细胞计数的患者，开高剂量或中剂量ICS的有效性和安全性尚不清楚。

著录项

期刊名称 International Journal of Chronic Obstructive Pulmonary Disease
作者
Shih-Lung Cheng; Ching-Hsiung Lin;
展开▼
作者单位

展开▼
年(卷),期 2016(11),-1
年度 2016
页码 2341–2348
总页数 8
原文格式 PDF
正文语种
中图分类呼吸生理学;
关键词
chronic obstructive pulmonary disease inhaled corticosteroid blood eosinophil;

机译：慢性阻塞性肺疾病;吸入糖皮质激素;血液嗜酸性粒细胞;

相似文献

外文文献
中文文献
专利

1. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts [J] . Shih-Lung Cheng, Ching-Hsiung Lin International Journal of Chronic Obstructive Pulmonary Disease . 2016,第1期

机译：通过不同的嗜酸细胞计数，使用较高的吸入糖皮质激素剂量治疗COPD患者的有效性
2. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis [J] . Timothy H. Harries, Victoria Rowland, Christopher J. Corrigan, Respiratory Research . 2020,第1期

机译：血嗜酸性粒细胞计数，一种吸入皮质类固醇效应的标志物，防止HOC后rct和观察研究中的COCD加剧：系统评价和荟萃分析
3. Absolute Blood Eosinophil Counts to Guide Inhaled Corticosteroids Therapy Among Patients with COPD: Systematic Review and Meta-analysis [J] . Olorunfemi A. Oshagbemi, Jephthah O. Odiba, Abraham Daniel, Current drug targets-The International journal for timely in-depth reviews on drug targets . 2019,第16期

机译：绝对血嗜酸性粒细胞计数，以指导COPD患者吸入的皮质类固醇治疗：系统审查和荟萃分析
4. Expression of surface markers on peripheral CD4<'+>CD25<'high> T cells in patients with atopic asthma: role of inhaled corticosteroid [C] . Cao Shukun, rnXu Jing, rnShi Lei, Journal of Organ Dysfunction: ISRD 2007 Abstract Book . 2007

机译：特应性哮喘患者外周血CD4'+ CD25 <'high> T细胞表面标志物的表达：吸入糖皮质激素的作用
5. Addition of leukotriene receptor antagonists versus long acting beta agonists to inhaled corticosteroid therapy for asthma treatment in older adults: A retrospective data analysis of effectiveness, safety and cost. [D] . Altawalbeh, Shoroq Mahmoud. 2015

机译：在吸入性糖皮质激素治疗中，将白三烯受体拮抗剂与长效β激动剂相比，用于老年人的哮喘治疗：有效性，安全性和成本的回顾性数据分析。
6. Blood eosinophil count a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis [O] . Timothy H. Harries, Victoria Rowland, Christopher J. Corrigan, 2020

机译：血液嗜酸性粒细胞计数在事后RCT和观察性研究中吸入皮质类固醇预防COPD恶化的有效性的标志：系统评价和荟萃分析
7. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts [O] . Shih-Lung Cheng, Ching-Hsiung Lin 2016

机译：用不同血液嗜酸性统计计数患者使用较高吸入皮质类固醇剂量的有效性

Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅